UK allergy treatment developer Circassia, backed by several investors, plans on raising a total of £209m in its debut on the London Stock Exchange next week, giving it a market cap of £581m.
E-commerce business has made several add-ons since Emeram bought a majority stake in 2015
Fund invests in Nordic companies operating in the consumer, industrial and business services sectors
Insight Venture Partners previously led a €56m funding round early last year
Price led the strategic debt finance and capital structure advisory teams at Lloyds